About BBCRI

Bhutan Biotech Centre for Research and Innovation

An early-stage biotech company in Thimphu, connecting Bhutan's medicinal heritage with modern science.

Who we are

An early-stage biotech company in Thimphu, connecting Bhutan's medicinal heritage with modern science.

BBCRI is building Sowa-Omics™, a research platform that brings together Sowa Rigpa, Bhutanese medicinal plants, omics data and AI. The aim is to find promising therapeutic leads and test them properly.

We start from what people already use. We digitise traditional formulas, trace each ingredient to its compounds and use computational tools to link those compounds to biological targets. The strongest candidates go forward to laboratory validation with research partners.

We are a small founding team with a working prototype. Our job now is to build the data, the partnerships and the lab capacity to take this from prototype to evidence.

The opportunity we see

Sowa Rigpa holds centuries of human-use experience with medicinal formulas, yet almost none of it has been mapped to molecular targets. That is an untapped discovery pipeline. BBCRI is building the proprietary data, AI and lab partnerships to turn it into licensable leads and products.

Why Bhutan

How we work

Proprietary data

Digitised, structured Sowa Rigpa formulas linked to plants, compounds and targets: a dataset that does not exist anywhere else.

Compliant access

Built around Bhutan's access and benefit-sharing framework and the Nagoya Protocol, crediting knowledge holders. Lawful access is a barrier competitors cannot easily cross.

Capital-light, AI-first

Computation narrows thousands of candidates before any lab work, and partners run the assays. Less burn, faster answers.

Evidence over claims

Nothing is called a therapy until it is validated. That discipline is what partners, regulators and customers pay for.

Where we are today

We are at the very beginning, and we say so plainly. BBCRI has a small founding team and a working software prototype of the Sowa-Omics™ platform. We are registering in Gelephu Mindfulness City and are open to conversations with research partners and seed investors.

  1. Foundation (current phase)Working platform prototype; Register in Gelephu Mindfulness City; First pilot partners.
  2. SeedSeed funding; Curated plant, formula and compound database; Agreements with labs and Sowa Rigpa institutions.
  3. First revenueResearch services; First wet-lab validated leads; First evidence-backed product.
  4. ScaleCo-development deals with industry partners; Own R&D facility; Therapeutic and wellness product line.

At a glance

Based in
Thimphu, Bhutan
Founder
Ramesh Bahadur Subba
Platform
Sowa-Omics™
Focus
AI-enabled drug discovery, natural products and preventive wellness
Stage
Prototype platform, founding team
GMC
Registering in Gelephu Mindfulness City
Contact
ramesh@bbcri.online · +975 77476075
Follow
LinkedIn · Instagram · Facebook

Meet the team, see what we are researching, or find out how to invest or partner.

Start a conversation.

Investors, partners and customers: tell us what you have in mind. We reply to every message.

Email ramesh@bbcri.online Invest or partner